Pregnancy and Metabolic-associated Fatty Liver Disease: A Clinical Update

Overview

Journal J Clin Transl Hepatol

Specialty Gastroenterology

Date 2022 Oct 28

PMID 36304500

Authors

Sherouk Fouda

Madhu Mathew Vennikandam

Joseph M Pappachan

Cornelius J Fernandez

Affiliations

Soon will be listed here.

Abstract

The intricate relationship between metabolic-associated fatty liver disease (MAFLD) and maternal complications has rapidly become a significant health threat in pregnant women. The presence of MAFLD in pregnancy increases the maternal risk of metabolic complications and comorbidities for both mother and baby. The preexistence or development of MAFLD in pregnancy is a complex multifactorial disorder that can lead to further complications for mother and baby. Therefore, as pregnant women are severely underrepresented in clinical research, there is a great need for a fair inclusion of this group in clinical trials. This review aims to explore the effects of MAFLD during pregnancy in the context of maternal complications and outcomes and explore the effects of pregnancy on the development and progression of MAFLD within the context of maternal obesity, altered metabolic profiles, gestational diabetes and altered hormonal profiles. We also addressed potential implications for the presence of MAFLD during pregnancy and its management in the clinical setting.

Citing Articles

Current Therapeutic Landscape for Metabolic Dysfunction-Associated Steatohepatitis.

Devasia A, Ramasamy A, Leo C Int J Mol Sci. 2025; 26(4).

PMID: 40004240 PMC: 11855529. DOI: 10.3390/ijms26041778.

Metabolic dysfunction-associated steatotic liver disease across women's reproductive lifespan and issues.

Meda C, Dolce A, Della Torre S Clin Mol Hepatol. 2024; 31(1):327-332.

PMID: 39098816 PMC: 11791579. DOI: 10.3350/cmh.2024.0419.

Adipose tissue-liver cross-talk: a route to hepatic dysfunction in pregnant women with obesity.

Sousa D, Magalhaes C, Matafome P, Pereira S Biosci Rep. 2024; 44(8).

PMID: 39083072 PMC: 11327218. DOI: 10.1042/BSR20231679.

Metabolic Dysfunction-associated Fatty Liver Disease: An Urgent Call for Global Action.

Fernandez C, Nagendra L, Pappachan J touchREV Endocrinol. 2024; 20(1):5-9.

PMID: 38812662 PMC: 11132654. DOI: 10.17925/EE.2023.20.1.1.

Liver imaging and pregnancy: what to expect when your patient is expecting.

Porrello G, Cannella R, Bernuau J, Agman A, Brancatelli G, Dioguardi Burgio M Insights Imaging. 2024; 15(1):66.

PMID: 38411871 PMC: 10899155. DOI: 10.1186/s13244-024-01622-x.

References

Armstrong M, Adams L, Canbay A, Syn W . Extrahepatic complications of nonalcoholic fatty liver disease. Hepatology. 2013; 59(3):1174-97. DOI: 10.1002/hep.26717. View

Kim T, Hong D, Yang Y . Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism. Biomedicines. 2021; 9(12). PMC: 8698516. DOI: 10.3390/biomedicines9121903. View

Valenti L, Bugianesi E, Pajvani U, Targher G . Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?. Liver Int. 2016; 36(11):1563-1579. DOI: 10.1111/liv.13185. View

Sivan E, Homko C, Chen X, Reece E, Boden G . Effect of insulin on fat metabolism during and after normal pregnancy. Diabetes. 1999; 48(4):834-8. DOI: 10.2337/diabetes.48.4.834. View

Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio L . Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet. 2008; 40(12):1461-5. PMC: 2597056. DOI: 10.1038/ng.257. View

Sarkar M, Brady C, Fleckenstein J, Forde K, Khungar V, Molleston J . Reproductive Health and Liver Disease: Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2020; 73(1):318-365. DOI: 10.1002/hep.31559. View

Hagstrom H, Hoijer J, Ludvigsson J, Bottai M, Ekbom A, Hultcrantz R . Adverse outcomes of pregnancy in women with non-alcoholic fatty liver disease. Liver Int. 2015; 36(2):268-74. DOI: 10.1111/liv.12902. View

Ofosu A, Ramai D, Reddy M . Non-alcoholic fatty liver disease: controlling an emerging epidemic, challenges, and future directions. Ann Gastroenterol. 2018; 31(3):288-295. PMC: 5924851. DOI: 10.20524/aog.2018.0240. View

Grossmann M, Wierman M, Angus P, Handelsman D . Reproductive Endocrinology of Nonalcoholic Fatty Liver Disease. Endocr Rev. 2018; 40(2):417-446. DOI: 10.1210/er.2018-00158. View

10.

Paik J, Kabbara K, Eberly K, Younossi Y, Henry L, Younossi Z . Global burden of NAFLD and chronic liver disease among adolescents and young adults. Hepatology. 2021; 75(5):1204-1217. DOI: 10.1002/hep.32228. View

11.

Ajmera V, Gunderson E, VanWagner L, Lewis C, Carr J, Terrault N . Gestational Diabetes Mellitus Is Strongly Associated With Non-Alcoholic Fatty Liver Disease. Am J Gastroenterol. 2016; 111(5):658-64. PMC: 4860097. DOI: 10.1038/ajg.2016.57. View

12.

Saengnipanthkul S, Noh H, Friedline R, Suk S, Choi S, Acosta N . Maternal exposure to high-fat diet during pregnancy and lactation predisposes normal weight offspring mice to develop hepatic inflammation and insulin resistance. Physiol Rep. 2021; 9(6):e14811. PMC: 7995551. DOI: 10.14814/phy2.14811. View

13.

McMillen I, Robinson J . Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev. 2005; 85(2):571-633. DOI: 10.1152/physrev.00053.2003. View

14.

Crume T, Ogden L, West N, Vehik K, Scherzinger A, Daniels S . Association of exposure to diabetes in utero with adiposity and fat distribution in a multiethnic population of youth: the Exploring Perinatal Outcomes among Children (EPOCH) Study. Diabetologia. 2010; 54(1):87-92. PMC: 3027214. DOI: 10.1007/s00125-010-1925-3. View

15.

Lee C, Kim J, Jung Y . Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis. Cells. 2019; 8(10). PMC: 6835656. DOI: 10.3390/cells8101259. View

16.

Abeysekera K, Orr J, Madley-Dowd P, Fernandes G, Zuccolo L, Gordon F . Association of maternal pre-pregnancy BMI and breastfeeding with NAFLD in young adults: a parental negative control study. Lancet Reg Health Eur. 2021; 10:100206. PMC: 8589711. DOI: 10.1016/j.lanepe.2021.100206. View

17.

Dontje M, Eastwood P, Straker L . Western Australian pregnancy cohort (Raine) Study: Generation 1. BMJ Open. 2019; 9(5):e026276. PMC: 6549642. DOI: 10.1136/bmjopen-2018-026276. View

18.

Goldner D, Lavine J . Nonalcoholic Fatty Liver Disease in Children: Unique Considerations and Challenges. Gastroenterology. 2020; 158(7):1967-1983.e1. DOI: 10.1053/j.gastro.2020.01.048. View

19.

Younossi Z, Koenig A, Abdelatif D, Fazel Y, Henry L, Wymer M . Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2015; 64(1):73-84. DOI: 10.1002/hep.28431. View

20.

Mousa N, Abdel-Razik A, Shams M, Sheta T, Zakaria S, Shabana W . Impact of non-alcoholic fatty liver disease on pregnancy. Br J Biomed Sci. 2018; 75(4):197-199. DOI: 10.1080/09674845.2018.1492205. View